Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sun European Partners, the European adviser to US investment group Sun Capital Partners, has agreed to acquire UK-based NextPharma Technologies, a provider of outsourcing services to the pharmaceutical and biotechnology industries.
Subscribe to our email newsletter
NextPharma has over through 200 clients across the biotech, pharma and healthcare sectors.
NextPharma provides manufacturing, product development, clinical trials and logistics services through its seven manufacturing facilities, seven product development centres and six temperature-controlled storage and distribution sites across Europe and the US.
Altassets.com has quoted Sun European Partners vice president Matthias Gundlach as saying that NextPharma, with its strong track record, reputation and state of the art facilities, is well positioned to capitalise on the trend of pharmaceutical companies farming out aspects of the product development cycle to outsourcing firms.